Browsing by Author "Topkan, Erkan"
Now showing 1 - 20 of 120
- Results Per Page
- Sort Options
Item Baseline hemoglobin <11.0 g/dL has stronger prognostic value than anemia status in nasopharynx cancers treated with chemoradiotherapy(2019) Topkan, Erkan; Ekici, Nur Yucel; Ozdemir, Yurday; Besen, Ali Ayberk; Yildirim, Berna Akkus; Mertsoylu, Huseyin; Sezen, Duygu; Selek, Ugur; 30864463Background: To retrospectively investigate the influence of pretreatment anemia and hemoglobin levels on the survival of nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy (C-CRT). Methods: A total of 149 nasopharyngeal carcinoma patients who received C-CRT were included. All patients had received 70 Gy to the primary tumor plus the involved lymph nodes, and 59.4 Gy and 54 Gy to the intermediate- and low-risk neck regions concurrent with 1-3 cycles of cisplatin. Patients were dichotomized into non-anemic and anemic (hemoglobin <12 g/dL (women) or <13 g/dL (men)) groups according to their pre-treatment hemoglobin measures. Receiver operating characteristic (ROC) curve analysis was utilized for accessibility of a pre-treatment hemoglobin cut-off that impacts outcomes. Potential interactions between baseline anemia status and hemoglobin measures and overall survival, locoregional progression-free survival (LRPFS), and progression-free survival were assessed. Results: Anemia was evident in 36 patients (24.1%), which was related to significantly shorter overall survival (P=0.007), LRPFS (P<0.021), and progression-free survival (P=0.003) times; all three endpoints retained significance in multivariate analyses (P<0.05, for each). A baseline hemoglobin value of 11.0 g/dL exhibited significant association with outcomes in ROC curve analysis: hemoglobin <11.0 g/dL (N=26) was linked with shorter median overall survival (P<0.001), LRPFS (P=0.004), and progression-free survival (P<0.001) times, which also retained significance for all three endpoints in multivariate analyses and suggested a stronger prognostic worth for the hemoglobin Conclusion: Pre-C-CRT hemoglobin <11.0 g/dL has a stronger prognostic worth than the anemia status with regard to LRPFS, progression-free survival, and overall survival for nasopharyngeal carcinoma patients.Item Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy(2019) Topkan, Erkan; Yucel Ekici, Nur; Ozdemir, Yurday; Besen, Ali Ayberk; Mertsoylu, Huseyin; Sezer, Ahmet; Selek, Ugur; 31184210Background: To retrospectively assess the impact of prognostic nutritional index (PNI) on survival outcomes of patients with locoregionally advanced nasopharyngeal carcinoma (LA-NPC) treated with concurrent chemoradiotherapy (CCRT). Methods: This study incorporated 154 patients with LA-NPC who received exclusive cisplatinum-based CCRT. Receiver operating characteristic (ROC) curve analysis was utilized for accessibility of pretreatment PNI cutoffs influencing survival results. The primary end point was the interaction between the overall survival (OS) and PNI values, while cancer-specific survival (CSS) locoregional progression-free survival (LR-PFS), distant metastasis-free survival (DMFS), and PFS were the secondary end points. Results: A rounded PNI cutoff value of 51 was identified in ROC curve analyses to exhibit significant link with CSS, OS, DMFS, and PFS outcomes, but not LR-PFS. Patients grouping per PNI value (>= 51 [N = 95] vs <51 [N = 49]) revealed that PNI < 51 group had significantly shorter median CSS (P< .001), OS (P< .001), DMFS (P< .001), and PFS (P< .001) times than the PNI >= 51 group, and the multivariate results confirmed the PNI < 51 as an independent predictor of poor outcomes for each end point (P< .05 for each). The unfavorable impact of the low PNI was also continued at 10-year time point with survival rates of 77.9% versus 42.4%, 73.6% versus 33.9%, 57.9% versus 27.1%, and 52.6% versus 23.7% for CSS, OS, DMFS, and PFS, respectively. Additionally, we found that PNI < 51 was significantly associated with higher rates of weight loss >5% over past 6 months (49.2% versus 11.6%;P= .002) compared to PNI < 51 group. Conclusion: Low pre-CCRT PNI levels were independently associated with significantly reduced CSS, OS, DMFS, and PFS outcomes in patients with LA-NPC treated with definitive CCRT.Item Chemoradiotherapy-İnduced Hemoglobin Nadir Values And Survival in Patients With Stage III Non-Small Cell Lung Cancer(2018) Topkan, Erkan; Selek, Ugur; Ozdemir, Yurday; Yildirim, Berna A.; Guler, Ozan C.; Mertsoylu, Huseyin; Hahn, Stephen M.; https://orcid.org/0000-0001-8120-7123; https://orcid.org/0000-0002-2218-2074; https://orcid.org/0000-0001-6661-4185; https://orcid.org/0000-0001-6908-3412; https://orcid.org/0000-0002-1932-9784; 29858023; AAG-2213-2021; AAG-5629-2021; V-5717-2017; AAC-5654-2020; M-9530-2014Purpose: We investigated the influence of change in hemoglobin (Hgb) levels during concurrent chemoradiotherapy (C-CRT) on outcomes of non-anemic patients with stage IIIA/B non-small cell lung cancer (NSCLC). Methods: We identified 722 patients with stage IIIA/B NSCLC without anemia at baseline [hemoglobin (Hgb) < 12 g/dL for women or < 13 g/dL for men], either nonsmokers or ex-smokers, who received C-CRT between 2007 and 2012. All patients had received 1 - 3 cycles of platinum-based doublet chemotherapy during radiotherapy to 60 - 66 Gy and had documented Hgb measurements before treatment and at weekly intervals for 6 weeks during the C-CRT. Potential associations were assessed between baseline, nadir, extent of change in Hgb level, and anemia and overall survival (OS), locoregional progression-free survival (LRPFS), and PFS. Results: The median baseline Hgb level was 13.9 g/dL (range 12.0-16.8) and declined to a median 12.4 g/dL (range 7.9-16.1) during treatment. Anemia appeared in 237 patients (32.8%) and was more common among women (44.8% vs. 26.5%, P < 0.001). Neither baseline Hgb level nor change during treatment nor anemia emergence influenced any survival endpoint. Receiver operating curve analysis revealed an Hgb nadir of 11.1 g/dL to be associated with outcomes, in that a nadir Hgb < 11.1 g/dL (in 156 patients) was linked with shorter median OS time (P < 0.001), LRPFS time (P < 0.001), and PFS time (P < 0.001); retained significance for all three endpoints in multivariate analyses; and was more strongly associated with OS in squamous cell carcinoma (P < 0.001) than in adenocarcinoma (P = 0.009). Conclusion: Nadir Hgb < 11.1 g/dL levels during C-CRT were associated with significantly poorer survival times in initially non-anemic patients presenting with locally advanced NSCLC.Item Comment on "Management of 80 Sinonasal Undifferentiated Carcinomas. Retrospective Multicentre Study of the French Network of Rare Head and Neck Cancers (REFCOR).(Başkent Üniversitesi Diş Hekimliği Fakültesi, 2024-06-21) Topkan, Erkan; Somay, Efsun; Selek, UgurItem Comment on "Predictors of Prolonged Teatment Time Intervals in Oral Cavity Cancer"(ORAL ONCOLOGY, 2024-01) Topkan, Erkan; Somay, Efsun; Selek, UgurItem Comment on 'Accelerated Hypofractionated Chemoradiation For Locally Advanced Head And Neck Cancer During Covid-19 Pandemic: A Tertiary Care Experience'(Başkent Üniversitesi Diş Hekimliği Fakültesi, 2024-10-30) Somay, Efsun; Topkan, Erkan; Selek, Ugur; Pehlivan, BerrinItem Comment on Poor Dental Health as a Risk Factor for Alveolar Ridge Malignancies(Başkent Üniversitesi Diş Hekimliği Fakültesi, 2024-03-21) Somay, Efsun; Topkan, ErkanItem Comment on Poor Dental Health as a Risk Factor for Alveolar Ridge Malignancies(Başkent Üniversitesi Diş Hekimliği Fakültesi, 2024-03-21) Somay, Efsun; Topkan, ErkanItem Comment on Poor Dental Health as a Risk Factor for Alveolar Ridge Malignancies(Başkent Üniversitesi Diş Hekimliği Fakültesi, 2024-03-21) Somay, Efsun; Topkan, ErkanItem Comment On Prospective Comparison Of Acute Severe Toxicities Between Smokers And Non-Smokers During Radiotherapy For Head And Neck Cancers(Başkent Üniversitesi Diş Hekimliği Fakültesi, 2024-07-08) Topkan, Erkan; Somay, Efsun; Bascil, Sibel; Selek, UgurItem Comment on Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis(Başkent Üniversitesi Tıp Fakültesi, 2025) Somay, Efsun; Bascil, Sibel; Topkan, Erkan; Selek, Ugur; 41396789Item Comment on: Intensity Modulated Radiotherapy in Head and Neck Cancer: Initial Experience of the First Treated Cases from North-East India(2023) Topkan, Erkan; Somay, Efsun; Selek, Ugur; 0000-0001-8251-6913; 38187854; AAG-2213-2021; O-5474-2014Item Comment on: Long-Term Effects of Chemotherapy and Radiation Received During Early Childhood on The Developing Dentition of Pediatric Cancer Patients(SPECIAL CARE IN DENTISTRY, 2024) Somay, Efsun; Topkan, Erkan; Selek, UgurItem Comment on: Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study(2022) Topkan, Erkan; Somay, Efsun; Yilmaz, Busra; Kucuk, Ahmet; 0000-0003-0633-5648; 36041356Item Comment on: Quality of Life After Segmental Mandibulectomy and Free Flap for Mandibular Osteonecrosis: Systematic Review(2023) Topkan, Erkan; Somay, Efsun; 0000-0001-8251-6913; 37459741; AAG-2213-2021Item Comment On: Radiotherapy And Long-Term Sequelae In Pediatric Patients With Parameningeal Rhabdomyosarcoma: Results Of Two Cooperative Weichteilsarkom Studiengruppe (Cws) Trials And One Registry(PEDIATRIC BLOOD & CANCER, 2024-01-31) Somay, Efsun; Topkan, Erkan; Selek, UgurItem Comment on: Required Time for Pre-Oncological Dental Management-A Rapid Review of the Literature(2022) Topkan, Erkan; Somay, Efsun; Yilmaz, Busra; Kucuk, Ahmet; 0000-0001-8120-7123; 0000-0003-0633-5648; 36183502; AAG-2213-2021; AAR-6904-2020Item Comment On: Risk Prediction Of Complicated Course In Patients Undergoing Major Head And Neck Surgery With Free Fl Ap Reconstruction(BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2024-12) Topkan, Erkan; Somay, Efsun; Ozturk, Duriye; Senyurek, SukranItem Commentary On "Effect Analysis Of 847 Nasopharyngeal Carcinoma Cases Treated With Intensity Modulated Radiation: Experience And Suggestions"(ORAL ONCOLOGY, 2024-12) Topkan, Erkan; Somay, Efsun; Ozturk, Duriye; Selek, UgurItem Comments on "Accounting for Fractionation and Heterogeneous Dose Distributions in the Modelling of Osteoradionecrosis in Oropharyngeal Carcinoma Treatment"(Başkent Üniversitesi Diş Hekimliği Fakültesi, 2024-03-25) Somay, Efsun; Yilmaz, Busra; Topkan, Erkan